Blue Trust’s Amryt Pharma AMYT Stock Holding History
Bought
Maintained
Sold
Blue Trust's AMYT Position: Q2 2023 in Review
Blue Trust sold out of Amryt Pharma (AMYT) in Q2 2023, closing a stake of 170 shares — an estimated $1K sold.
Blue Trust first reported a position in AMYT in Q3 2022 and held it in 3 quarters. The position peaked at $2K in Q3 2022. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.
- Blue Trust reported no remaining Amryt Pharma position as of Q2 2023 after selling out during the quarter.
- Blue Trust sold 170 Amryt Pharma shares in Q2 2023, an estimated $1K.
- Blue Trust first reported a position in Amryt Pharma in Q3 2022 and held it in 3 quarters.
- Blue Trust's Amryt Pharma position peaked at $2K in Q3 2022.
- 0 funds tracked by Wall St. Rank held Amryt Pharma as of Q2 2023.
Based on Blue Trust's 13F filing for Q2 2023, filed 14 Jul 2023.